Results from the CheckMate649 trial support the use of nivolumab plus chemotherapy in the treatment of advanced gastric cancers.
ONCOLOGY® Companion, Volume 39, Supplement 2
A cancer care team contemplated the methods and reasoning for handling a complex case of heavily pretreated relapsed or refractory multiple myeloma.
James Zoeller discussed various aspects of his cancer care after a RCC diagnosis with Hannah D. McManus, MD, and Allison Brown, BSN, RN, RN-BC.
Advertisement
Advertisement
Trending on CancerNetwork
1
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
2
ASCO Releases New Patient-Clinician Communication Guidelines
3
Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma
4
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
5